Please enable JavaScript to continue using this application.

Compare $ACHV vs $ANNX | Chartloom

Compare

$ACHV vs $ANNX

Achieve Life Sciences Inc · Annexon Inc

ACHV

Achieve Life Sciences Inc

ANNX

Annexon Inc

Compare $ACHV vs $ANNX

Comparing Achieve Life Sciences Inc and Annexon Inc

ACHVAchieve Life Sciences Inc

ANNXAnnexon Inc

ACHVAchieve Life Sciences Inc

Market cap

$761M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-89.3%

YTD performance

49.1%

52W performance

114.8%

FCF yield

-6.2%

ANNXAnnexon Inc

Market cap

$659M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

21.66x

Rev growth (TTM)

—

YTD performance

-14.3%

52W performance

27.6%

FCF yield

-29.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACHV

ANNX

Detailed metrics comparison

ACHV

Achieve Life Sciences Inc

ANNX

Annexon Inc

Market Cap

ACHV$761M

ANNX$659M

Enterprise Value

ACHV$728M

ANNX$459M

Price

ACHV$7.41

ANNX$4.02

P/E Ratio

ACHVN/A

ANNXN/A

P/S Ratio

ACHV41.81x

ANNX0.00x

EV/Sales

ACHV39.95x

ANNX0.00x

EV/EBITDA

ACHV0.00x

ANNX0.00x

P/B Ratio

ACHV69.77x

ANNX4.27x

P/FCF Ratio

ACHVN/A

ANNXN/A

EV/FCF

ACHV-15.41x

ANNX-2.38x

PEG Ratio

ACHVN/A

ANNXN/A

Forward P/E (NTM)

ACHVN/A

ANNXN/A

Forward P/S (NTM)

ACHVN/A

ANNX21.66x

Revenue (TTM)

ACHV$0

ANNX$0

Revenue Growth (YoY)

ACHV-89.3%

ANNXN/A

Forward Rev Growth

ACHV281.2%

ANNX370.6%

Gross Margin (TTM)

ACHV0.0%

ANNX0.0%

Operating Margin (TTM)

ACHV0.0%

ANNX0.0%

EBITDA Margin (TTM)

ACHV0.0%

ANNX0.0%

Net Margin (TTM)

ACHV0.0%

ANNX0.0%

FCF Margin (TTM)

ACHVN/A

ANNXN/A

Net Income (TTM)

ACHV$-114M

ANNX$-203M

FCF (TTM)

ACHV$-47M

ANNX$-193M

EPS (TTM)

ACHV-$1.22

ANNX-$1.01

ROE (TTM)

ACHV-19349.0%

ANNX-10615.0%

ROA (TTM)

ACHV-14373.0%

ANNX-7982.0%

ROIC (TTM)

ACHV-13245.0%

ANNX-10615.0%

Cash

ACHV$48M

ANNX$199M

Debt

ACHV$15M

ANNX$0

Net Cash/Debt

ACHV$33M

ANNX$199M

Current Ratio (TTM)

ACHV0.95x

ANNX5.53x

Quick Ratio (TTM)

ACHV0.95x

ANNX5.44x

Debt/Equity (TTM)

ACHV1.40x

ANNX0.00x

Debt/Assets (TTM)

ACHV0.0%

ANNX0.0%

Interest Coverage (TTM)

ACHVN/A

ANNXN/A

Net Debt/EBITDA (TTM)

ACHV0.00x

ANNX0.00x

Beta

ACHV2.44

ANNX1.40

52W Performance

ACHV114.8%

ANNX27.6%

YTD Performance

ACHV49.1%

ANNX-14.3%

% from 52W High

ACHV-14.2%

ANNX-44.0%

% from 52W Low

ACHV182.8%

ANNX58.3%

Asset Turnover (TTM)

ACHV0.33x

ANNX0.00x

FCF Yield (TTM)

ACHV-6.2%

ANNX-29.3%

Earnings Yield (TTM)

ACHV-15.0%

ANNX-30.8%

Dividend Yield (TTM)

ACHVN/A

ANNXN/A

Rule of 40

ACHV-89.3

ANNX0.0

EV/GP/RG

ACHVN/A

ANNXN/A

Ticker research

View ACHV research View ANNX research

Metric	ACHV Achieve Life Sciences Inc	ANNX Annexon Inc
Market & Valuation
Market Cap	$761M	$659M
Enterprise Value	$728M	$459M
Price	$7.41	$4.02
P/E Ratio	N/A	N/A
P/S Ratio	41.81x	0.00x
EV/Sales	39.95x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	69.77x	4.27x
P/FCF Ratio	N/A	N/A
EV/FCF	-15.41x	-2.38x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	21.66x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-89.3%	N/A
Forward Rev Growth	281.2%	370.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-114M	$-203M
FCF (TTM)	$-47M	$-193M
EPS (TTM)	-$1.22	-$1.01
ROE (TTM)	-19349.0%	-10615.0%
ROA (TTM)	-14373.0%	-7982.0%
ROIC (TTM)	-13245.0%	-10615.0%
Financial Health
Cash	$48M	$199M
Debt	$15M	$0
Net Cash/Debt	$33M	$199M
Current Ratio (TTM)	0.95x	5.53x
Quick Ratio (TTM)	0.95x	5.44x
Debt/Equity (TTM)	1.40x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.44	1.40
52W Performance	114.8%	27.6%
YTD Performance	49.1%	-14.3%
% from 52W High	-14.2%	-44.0%
% from 52W Low	182.8%	58.3%
Efficiency & Yields
Asset Turnover (TTM)	0.33x	0.00x
FCF Yield (TTM)	-6.2%	-29.3%
Earnings Yield (TTM)	-15.0%	-30.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-89.3	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACHV research	View ANNX research

Valuation

P/S Ratio

ANNX

0.00x

ACHV

41.81x

EV/FCF

ACHV

-15.41x

ANNX

-2.38x

Growth & revenue

Revenue Growth TTM

ACHV

-89.3%

Forward Revenue Growth

ANNX

370.6%

ACHV

281.2%

Profitability & performance

Gross Margin

ACHV

0.0%

ANNX

0.0%

ROE

ANNX

-10615.0%

ACHV

-19349.0%

FCF Yield %

ACHV

-6.2%

ANNX

-29.3%

52-Week Performance

ACHV

114.8%

ANNX

27.6%

Detailed metrics comparison

ACHV

Achieve Life Sciences Inc

ANNX

Annexon Inc

Market Cap

ACHV$761M

ANNX$659M

Enterprise Value

ACHV$728M

ANNX$459M

Price

ACHV$7.41

ANNX$4.02

P/E Ratio

ACHVN/A

ANNXN/A

P/S Ratio

ACHV41.81x

ANNX0.00x

EV/Sales

ACHV39.95x

ANNX0.00x

EV/EBITDA

ACHV0.00x

ANNX0.00x

P/B Ratio

ACHV69.77x

ANNX4.27x

P/FCF Ratio

ACHVN/A

ANNXN/A

EV/FCF

ACHV-15.41x

ANNX-2.38x

PEG Ratio

ACHVN/A

ANNXN/A

Forward P/E (NTM)

ACHVN/A

ANNXN/A

Forward P/S (NTM)

ACHVN/A

ANNX21.66x

Revenue (TTM)

ACHV$0

ANNX$0

Revenue Growth (YoY)

ACHV-89.3%

ANNXN/A

Forward Rev Growth

ACHV281.2%

ANNX370.6%

Gross Margin (TTM)

ACHV0.0%

ANNX0.0%

Operating Margin (TTM)

ACHV0.0%

ANNX0.0%

EBITDA Margin (TTM)

ACHV0.0%

ANNX0.0%

Net Margin (TTM)

ACHV0.0%

ANNX0.0%

FCF Margin (TTM)

ACHVN/A

ANNXN/A

Net Income (TTM)

ACHV$-114M

ANNX$-203M

FCF (TTM)

ACHV$-47M

ANNX$-193M

EPS (TTM)

ACHV-$1.22

ANNX-$1.01

ROE (TTM)

ACHV-19349.0%

ANNX-10615.0%

ROA (TTM)

ACHV-14373.0%

ANNX-7982.0%

ROIC (TTM)

ACHV-13245.0%

ANNX-10615.0%

Cash

ACHV$48M

ANNX$199M

Debt

ACHV$15M

ANNX$0

Net Cash/Debt

ACHV$33M

ANNX$199M

Current Ratio (TTM)

ACHV0.95x

ANNX5.53x

Quick Ratio (TTM)

ACHV0.95x

ANNX5.44x

Debt/Equity (TTM)

ACHV1.40x

ANNX0.00x

Debt/Assets (TTM)

ACHV0.0%

ANNX0.0%

Interest Coverage (TTM)

ACHVN/A

ANNXN/A

Net Debt/EBITDA (TTM)

ACHV0.00x

ANNX0.00x

Beta

ACHV2.44

ANNX1.40

52W Performance

ACHV114.8%

ANNX27.6%

YTD Performance

ACHV49.1%

ANNX-14.3%

% from 52W High

ACHV-14.2%

ANNX-44.0%

% from 52W Low

ACHV182.8%

ANNX58.3%

Asset Turnover (TTM)

ACHV0.33x

ANNX0.00x

FCF Yield (TTM)

ACHV-6.2%

ANNX-29.3%

Earnings Yield (TTM)

ACHV-15.0%

ANNX-30.8%

Dividend Yield (TTM)

ACHVN/A

ANNXN/A

Rule of 40

ACHV-89.3

ANNX0.0

EV/GP/RG

ACHVN/A

ANNXN/A

Ticker research

View ACHV research View ANNX research

Metric	ACHV Achieve Life Sciences Inc	ANNX Annexon Inc
Market & Valuation
Market Cap	$761M	$659M
Enterprise Value	$728M	$459M
Price	$7.41	$4.02
P/E Ratio	N/A	N/A
P/S Ratio	41.81x	0.00x
EV/Sales	39.95x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	69.77x	4.27x
P/FCF Ratio	N/A	N/A
EV/FCF	-15.41x	-2.38x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	21.66x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-89.3%	N/A
Forward Rev Growth	281.2%	370.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-114M	$-203M
FCF (TTM)	$-47M	$-193M
EPS (TTM)	-$1.22	-$1.01
ROE (TTM)	-19349.0%	-10615.0%
ROA (TTM)	-14373.0%	-7982.0%
ROIC (TTM)	-13245.0%	-10615.0%
Financial Health
Cash	$48M	$199M
Debt	$15M	$0
Net Cash/Debt	$33M	$199M
Current Ratio (TTM)	0.95x	5.53x
Quick Ratio (TTM)	0.95x	5.44x
Debt/Equity (TTM)	1.40x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.44	1.40
52W Performance	114.8%	27.6%
YTD Performance	49.1%	-14.3%
% from 52W High	-14.2%	-44.0%
% from 52W Low	182.8%	58.3%
Efficiency & Yields
Asset Turnover (TTM)	0.33x	0.00x
FCF Yield (TTM)	-6.2%	-29.3%
Earnings Yield (TTM)	-15.0%	-30.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-89.3	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACHV research	View ANNX research